We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Saligram’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A126377 · Current
Licensed to practise in California · since 2013 · expires 2026-12-31 · Rajiv Gandhi University of Health Sciences, Dr. B.R. Ambedkar Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$225,993
Medicare paid this office $225,993 for 330 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Largest Original Medicare bills
Injection, denosumab, 1 mg
50
$113,109
—None
Return visit (30+ min)
228
$44,799
$102
Long return visit (40+ min)
65
$13,041
$142
New patient visit (60+ min)
51
$8,778
$172
Short return visit (20+ min)
92
$7,628
$65
See all 8 services
Every Original Medicare service billed
Injection, denosumab, 1 mg
50
$113,109
—None
Return visit (30+ min)
228
$44,799
$102
Long return visit (40+ min)
65
$13,041
$142
New patient visit (60+ min)
51
$8,778
$172
Short return visit (20+ min)
92
$7,628
$65
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
72
$5,310
$27
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
220
$4,319
$13
Injection of drug or substance under skin or into muscle
57
$1,584
$13
Who their Medicare patients are
330 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 10% · Women 68% · Also on Medicaid 15% · Health risk score 1.27. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
The office billed $684,012, Medicare allowed $292,351 and paid $225,993; for 10,128 services of 17 kinds; $139,733 of it was for drugs given in the office and $86,260 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
Original Medicare by year
2024
330
10,128
75
1.27
$684,012
$225,993
2023
328
11,120
74
1.15
$665,618
$216,406
2022
344
10,222
74
1.20
$617,594
$200,645
2021
298
4,538
73
1.20
$348,712
$119,706
2020
259
3,183
72
1.23
$233,379
$74,697
2019
372
6,387
72
1.33
$481,331
$134,376
2018
357
4,654
73
1.43
$433,229
$116,362
2017
435
3,662
72
1.42
$364,063
$89,139
2016
259
3,951
72
1.32
$198,223
$50,413
2015
257
2,108
73
1.14
$182,210
$70,604
2014
75
154
72
1.86
$29,007
$8,976
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
Original Medicare services billed in 2023
Injection, denosumab, 1 mg
51
$92,618
—None
Return visit (30+ min)
245
$47,672
$99
Long return visit (40+ min)
58
$12,841
$144
New patient visit (60+ min)
47
$8,663
$184
Short return visit (20+ min)
72
$6,837
$69
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
64
$5,051
$28
Injection of drug or substance under skin or into muscle
58
$1,660
$13
2022: 8 services
Original Medicare services billed in 2022
Injection, denosumab, 1 mg
49
$83,558
—None
Return visit (30+ min)
248
$49,455
$103
Injection, romosozumab-aqqg, 1 mg
13
$30,269
—None
Long return visit (40+ min)
72
$12,045
$140
New patient visit (60+ min)
55
$10,462
$190
Short return visit (20+ min)
85
$7,485
$71
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
61
$4,817
$30
Injection of drug or substance under skin or into muscle
66
$1,466
$13
2021: 9 services
Original Medicare services billed in 2021
Injection, denosumab, 1 mg
36
$41,253
—None
Return visit (30+ min)
187
$32,347
$111
Long return visit (40+ min)
50
$10,409
$158
New patient visit (60+ min)
40
$7,536
$188
Short return visit (20+ min)
78
$7,111
$76
New patient visit (45+ min)
26
$3,612
$139
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
43
$2,907
$31
Telephone medical discussion with physician, 21-30 minutes
23
$2,798
$108
Injection of drug or substance under skin or into muscle
44
$655
$13
2020: 9 services
Original Medicare services billed in 2020
Injection, denosumab, 1 mg
28
$34,261
—None
Return visit (30+ min)
149
$13,750
$73
Telephone medical discussion with physician, 11-20 minutes
69
$4,944
$65
Telephone medical discussion with physician, 21-30 minutes
43
$4,703
$94
Long return visit (40+ min)
33
$4,292
$107
Short return visit (20+ min)
46
$2,364
$46
Telephone medical discussion with physician, 5-10 minutes
48
$2,015
$37
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
33
$1,334
$27
Injection of drug or substance under skin or into muscle
33
$574
$12
2019: 8 services
Original Medicare services billed in 2019
Injection, denosumab, 1 mg
50
$59,405
—None
Return visit (30+ min)
267
$43,049
$86
Long return visit (40+ min)
66
$9,406
$118
Short return visit (20+ min)
112
$7,353
$54
New patient visit (60+ min)
26
$4,544
$175
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
40
$2,403
$30
New patient visit (45+ min)
15
$2,127
$142
Injection of drug or substance under skin or into muscle
56
$1,177
$15
2018: 8 services
Original Medicare services billed in 2018
Return visit (30+ min)
281
$45,396
$83
Injection, denosumab, 1 mg
31
$41,754
—None
Long return visit (40+ min)
79
$11,947
$112
Short return visit (20+ min)
78
$5,390
$57
New patient visit (60+ min)
30
$5,004
$167
Injection of drug or substance under skin or into muscle
40
$1,161
$18
Influenza vaccine split virus, preservative free
12
$522
$44
Administration of influenza virus vaccine
12
$309
$26
2017: 10 services
Original Medicare services billed in 2017
Return visit (30+ min)
278
$33,093
$79
Injection, denosumab, 1 mg
23
$23,695
—None
Short return visit (20+ min)
192
$13,301
$54
New patient visit (45+ min)
43
$5,283
$123
Fine needle aspiration using imaging guidance
28
$3,705
$120
New patient visit (30+ min)
41
$3,523
$86
Long return visit (40+ min)
18
$2,334
$111
Ultrasonic guidance for needle placement
28
$1,531
$51
Injection of drug or substance under skin or into muscle
28
$772
$20
Administration of influenza virus vaccine
11
$355
$32
2016: 5 services
Original Medicare services billed in 2016
Return visit (30+ min)
94
$11,964
$83
New patient visit (45+ min)
78
$9,656
$124
Short return visit (20+ min)
114
$9,344
$58
New patient visit (30+ min)
91
$7,675
$84
Injection of drug or substance under skin or into muscle
25
$703
$20
2015: 9 services
Original Medicare services billed in 2015
Return visit (30+ min)
152
$27,057
$94
Injection, denosumab, 1 mg
16
$14,069
—None
New patient visit (45+ min)
83
$11,677
$141
Short return visit (20+ min)
92
$7,754
$64
Long return visit (40+ min)
27
$3,705
$124
New patient visit (30+ min)
17
$1,481
$87
Blood glucose (sugar) level
97
$1,277
$5
Hemoglobin a1c level
45
$829
$13
Injection of drug or substance under skin or into muscle
20
$603
$24
2014: 3 services
Original Medicare services billed in 2014
Return visit (30+ min)
36
$3,468
$94
New patient visit (45+ min)
13
$1,940
$149
Short return visit (20+ min)
20
$1,364
$59
Medicaid work
$11,528 in 2023
Medicaid paid $11,528 for 144 billed services this clinician did in 2023, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
Largest Medicaid services in 2023
Return visit (30+ min)
144
$11,528
Medicaid work by year
2023
144
1
21
$11,528
2022
158
1
21
$12,012
2021
63
1
14
$4,558
2020
56
2
18
$3,626
2019
219
2
22
$13,413
2018
122
1
21
$7,692
See the largest Medicaid services in earlier years
2022
Largest Medicaid services in 2022
Return visit (30+ min)
158
$12,012
2021
Largest Medicaid services in 2021
Return visit (30+ min)
63
$4,558
2020
Largest Medicaid services in 2020
Return visit (30+ min)
43
$2,794
Short return visit (20+ min)
13
$832
2019
Largest Medicaid services in 2019
Return visit (30+ min)
206
$12,801
Short return visit (20+ min)
13
$612
2018
Largest Medicaid services in 2018
Return visit (30+ min)
122
$7,692
Drugs they prescribed that Part D paid
$975,872
Pharmacies billed $975,872 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,423) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.
1,007 generic and 1,193 brand-name prescriptions · $975,872 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Largest Part D drug costs
Trulicity
129
$195,502
$1,516
Ozempic
139
$163,577
$1,177
Mounjaro
115
$117,297
$1,020
Jardiance
74
$103,414
$1,397
Soliqua 100-33
31
$34,498
$1,113
See all 47 drugs
Every Part D drug this clinician prescribed
Trulicity
129
$195,502
$1,516
Ozempic
139
$163,577
$1,177
Mounjaro
115
$117,297
$1,020
Jardiance
74
$103,414
$1,397
Soliqua 100-33
31
$34,498
$1,113
Tresiba Flextouch U-100
52
$30,163
$580
Fiasp Flextouch
38
$25,885
$681
Tresiba Flextouch U-200
15
$22,419
$1,495
Toujeo Max Solostar
22
$18,951
$861
Farxiga
13
$14,412
$1,109
Toujeo Solostar
24
$14,103
$588
Humalog Kwikpen U-100
68
$13,488
$198
Januvia
13
$10,083
$776
Nano 2nd Gen Pen Needle
105
$8,950
$85
Lantus Solostar
70
$8,861
$127
Tirosint
17
$7,714
$454
Basaglar Kwikpen U-100
21
$7,400
$352
Novolog Flexpen
30
$6,587
$220
Gvoke Hypopen 2-Pack
11
$6,133
$558
Synthroid
68
$6,102
$90
Humalog
24
$5,908
$246
Levothyroxine
261
$4,702
$18
Liothyronine
37
$2,417
$65
Humalog Mix 75-25 Kwikpen
14
$2,382
$170
Metformin Hcl Er
113
$2,209
$20
Insulin Lispro Kwikpen U-100
14
$2,170
$155
Hydrocortisone
50
$2,099
$42
Novolog
12
$1,886
$157
Ultra-Fine Nano Pen Needle
17
$1,884
$111
Ultra-Fine Mini Pen Needle
17
$1,882
$111
Armour Thyroid
18
$1,764
$98
Metformin
91
$1,256
$14
Repaglinide
33
$1,148
$35
Risedronate
13
$1,081
$83
Alendronate
93
$1,059
$11
Droplet Pen Needle
13
$971
$75
Ultra-Fine Short Pen Needle
12
$919
$77
Testosterone Cypionate
15
$576
$38
Atorvastatin
52
$549
$11
Methimazole
75
$498
$7
Glipizide
33
$440
$13
Prednisone
23
$242
$11
Calcitriol
15
$213
$14
Losartan
17
$210
$12
Glipizide Er
12
$72
$6
Lisinopril
19
$70
$4
Dexamethasone
12
$19
$2
Year by year
Part D prescribing by year
2024
2,423
284
0% (0)
49%
$975,872
2023
2,165
259
0% (0)
51%
$1,104,968
2022
2,105
258
0% (0)
51%
$998,623
2021
1,705
232
0% (0)
49%
$716,711
2020
2,064
243
0% (0)
53%
$882,892
2019
2,123
257
0% (0)
53%
$749,697
2018
2,253
253
0% (0)
50%
$748,262
2017
1,744
264
0% (0)
56%
$577,520
2016
918
194
0% (0)
51%
$227,464
2015
974
134
0% (0)
31%
$130,108
2014
284
80
0% (0)
30%
$37,175
2013
110
31
0% (0)
—None
$8,284
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.